AMERICAN DEPOSITARY SHARES, EACH REPRESENTING 40 ORDINARY SHARES, NIS 0.1 PAR VALUE THERAPIX BIOSCIENCES LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • March 3rd, 2017 • Therapix Biosciences Ltd. • Pharmaceutical preparations • New York
Amendment to Private Placement AgreementPrivate Placement Agreement • March 3rd, 2017 • Therapix Biosciences Ltd. • Pharmaceutical preparations
THIS AMENDMENT TO PRIVATE PLACEMENT AGREEMENT (the “Amendment”) is made as of February 28, 2017 by and among Therapix Biosciences Ltd. (the “Company”) and Dr. Haim Amir (the “Investor”). The Company and the Investor is referred to collectively as the “Parties” and each separately as a “Party”.
Private Placement AgreementPrivate Placement Agreement • March 3rd, 2017 • Therapix Biosciences Ltd. • Pharmaceutical preparations
THIS PRIVATE PLACEMENT AGREEMENT (the “Agreement”) is made and entered into as of the 13th day of February, 2017 (the “Execution Date”), by and among Therapix Biosciences Ltd., a company organized under the laws of the State of Israel having its principal offices at Azrieli Center (Square Tower) 27th Fl., Tel Aviv Israel (the “Company”) and traded on Tel Aviv Stock Exchange Ltd. (the “TASE”) and on the OTCQB; and each of the investors specified and detailed in Annex A which has placed his signature beside his name and has executed this Agreement (each, an “Investor”; together, the "Investors"). The term Investors in this Agreement shall refer to each of the Investors, severally and not jointly, and without any joint responsibility among them, each according to his investment amount set forth next to his name in Annex A. The Company and each of the Investors is referred to collectively as the “Parties” and each separately as a “Party”.
